GSTC (GlobeStar Therapeutics) Total Equity: $-1.63 Mil (As of Jun. 2024)


What is GlobeStar Therapeutics Total Equity?

GlobeStar Therapeutics GSTC -99.00% Total Equity is $-1.63 Mil as of Jun. 2024.

GlobeStar Therapeutics's total equity for the quarter that ended in Jun. 2024 was $-1.63 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

GlobeStar Therapeutics Total Equity Historical Data

* Premium members only.

The historical data trend for GlobeStar Therapeutics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlobeStar Therapeutics Total Equity Chart

GlobeStar Therapeutics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.69 -0.66 -0.73 -1.20 -1.43

GlobeStar Therapeutics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.28 -1.43 -1.53 -1.47 -1.63

GlobeStar Therapeutics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

GlobeStar Therapeutics's Total Equity for the fiscal year that ended in Sep. 2023 is calculated as

Total Equity=Total Assets(Q: Sep. 2023 )-Total Liabilities(Q: Sep. 2023 )
=N/A-1.434
=N/A

GlobeStar Therapeutics's Total Equity for the quarter that ended in Jun. 2024 is calculated as

Total Equity=Total Assets(Q: Jun. 2024 )-Total Liabilities(Q: Jun. 2024 )
=0.084-1.709
=-1.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-1.63 Mil mean?
GlobeStar Therapeutics (GSTC) has a Total Equity of $-1.63 Mil as of Jun. 2024. The total amount of equity as record on a company's balance sheet. View historical data for GlobeStar Therapeutics and its competitors.
Is GlobeStar Therapeutics' Total Equity too high?
GlobeStar Therapeutics' current Total Equity is $-1.63 Mil.
How does GlobeStar Therapeutics' Total Equity compare to GBLX and ENDV?
GlobeStar Therapeutics' Total Equity of $-1.63 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for GlobeStar Therapeutics and its competitors. GlobeStar Therapeutics's current Total Equity is $-1.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlobeStar Therapeutics stock overvalued right now?
GlobeStar Therapeutics (GSTC) has a current Total Equity of $-1.63 Mil. The current Total Equity is $-1.63 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For GlobeStar Therapeutics (GSTC), the current Total Equity is $-1.63 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GlobeStar Therapeutics Business Description

Address 719 Jadewin Avenue, Richland, WA, USA, 99352
GlobeStar Therapeutics Corp is a clinical-stage pharmaceutical company introducing a patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company is focused on developing therapies for people with serious and life-threatening rare disorders.